Opinion Article - Biomedical Research (2018) Volume 29, Issue 11

The threat of carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-HvKP)

Chang-Ro Lee^1#, Kwang Seung Park^1#, Jung Hun Lee¹, Jeong Ho Jeon¹, Young Bae Kim², Byeong Chul Jeong¹ and Sang Hee Lee^1*

¹National Leading Research Laboratory of Drug Resistance Proteomics, Department of Biological Sciences, Myongji University, 116 Myongjiro, Yongin, Gyeonggido, Republic of Korea

²Biotechnology Program, North Shore Community College, 1 Ferncroft Road, Danvers, USA

^#These authors contributed equally to this work

*Corresponding Author:

Sang Hee Lee
Director of National Leading Research Laboratory
Department of Biological Sciences
Myongji University, Republic of Korea

Accepted on April 11, 2018

Abstract

Klebsiella pneumoniae is one of clinically important opportunistic pathogens responsible for community-acquired and nosocomial infections in immunocompromised individuals. The increasing prevalence of carbapenem-resistant K. pneumoniae (CRKP) poses a serious threat to public health worldwide. With antibiotic resistance, hypervirulent K. pneumoniae (HvKP) responsible for serious disseminated infections in both healthy and immunocompromised individuals has also emerged. Recently, the emergence of carbapenem-resistant hypervirulent K. pneumoniae (CR-HvKP) strains has become a great challenge to public health. In this paper, we discuss the emergence mechanisms of CRHvKP through analyzing features of CR-HvKP strains isolated in China, where both CRKP and HvKP strains are prevalent. These analyses suggest that more extensive surveillance is required to accurately assess the potential threat of the plasmid-mediated convergence of carbapenem-resistance and hypervirulence.

Keywords

Klebsiella pneumoniae, Carbapenem-resistance, Hypervirulence, Plasmid-mediated convergence.

Introduction

Antibiotic resistance is a serious public health crisis [1,2]. The gradual increase of carbapenemase-resistant (CR) Klebsiella pneumoniae is especially serious [3,4]. Several carbapenemases, such as K. pneumoniae Carbapenemases (KPC), carbapenemases of the oxacillinase-48 (OXA-48), and New Delhi metallo-β-lactamase (NDM) carbapenemases type, have been reported worldwide in K. pneumoniae [3-5]. Besides carbapenem resistance, another big problem of K. pneumoniae infection is the emergence of hypervirulent K. pneumoniae (HvKP) with hypervirulence [6-8]. This pathogen with the hypermucoviscous phenotype caused highly invasive infections, such as liver abscesses, in both healthy and immunocompromised individuals [7-9]. Unlike the classic K. pneumoniae (cKP), approximately half of all HvKP infections occur in young, healthy individuals [6,9]. Many reports have determined hypervirulence-associated factors, including a K1/K2 capsular serotype, ST23 sequence type, a pLVPK virulence plasmid, a KPHP1208 pathogenicity island, and several virulence factors, such as RmpA and aerobactin [6].

Antibiotic resistance of cKP is significantly high worldwide [3], but HvKP is rarely resistant to antibiotics, except for an intrinsic resistance to ampicillin [6,10]. However, recent many reports have shown the emergence of antibiotic-resistant HvKP strains [6]. Especially, the emergence of Carbapenem-Resistant HvKP (CR-HvKP) was reported in China, where both carbapenem-resistant cKP (CRKP) and carbapenemsusceptible HvKP strains are prevalent [6,11]. A recent study performed by Danxia et al. showed the emergence of CRHvKP ST11 strains caused by the transfer of a 170 kb pLVPKlike virulence plasmid into blaKPC-2-harboring ST11 CRKP stains [12]. The report provided a direct clue to plasmidmediated convergence of carbapenem-resistance and hypervirulence. To understand the emergence mechanism of CR-HvKP, we analysed all reported CR-HvKP isolates. The analysis results suggested the following important aspects: (i) another possible mechanism of plasmid-mediated gene spread (the horizontal transfer of resistance plasmids from CRKP into HvKP strains); (ii) requirement for conjugation experiment of plasmids between HvKP and CRKP.

The Analysis of all Reported CR-HvKP Strains

Before the study of Danxia et al., there have been 36 CRHvKP strains isolated in China between 2010 and 2018 [13-18]. Sequence types and genotypes of β-lactamase (bla) genes of 36 strains were summarized in Table 1. Notably, 34 (94%) of 36 strains have bla_KPC-2 and 18 (50%) belong to ST11. Because the predominant clone of CRKP is KPC-2- producing ST11 and the dominant clone of HvKP is ST23 in China [6,11,19-22], these investigations imply the possibility for the direct transmission of a virulence plasmid from HvKP to KPC-2-producing CRKP. Danxia et al. proved this possibility.

Interestingly, investigation of 36 CR-HvKP isolates in China suggests another possible mechanism of plasmid-mediated gene spread. ST23 is the predominant clone of HvKP strains with the K1 serotype and ST65 is one of the dominant clones of HvKP with the K2 serotype [6,23]. These sequence types were rarely found in CRKP strains [3]. Notably, 9 (25%) of 36 CR-HvKP strains belonged to ST65 or ST23 (Table 1). Like the case of ST11, these imply the possibility for the direct transmission of a resistance plasmid carrying bla_KPC-2 from CRKP to ST23 or ST65 HvKP strains. Because the first possibility (the transmission of a pLVP-like plasmid from HvKP to CRKP) based on sequence types of 36 CR-HvKP strains was proved, another possible mechanism (the transmission of the resistance plasmid from CRKP to HvKP) also should be investigated.

Table 1. Comparison of sequence types and genotypes of bla genes of 36 CR-HvKP strains isolated in China between 2010 and 2018 and 5 CRHvKP strains from Danxia et al.’s study.

Danxia et al. showed that resistance plasmids harboring the bla_KPC-2 gene of 5 CR-HvKP ST11 strains could be transferred to the Escherichia coli strain through conjugation experiments, but they did not examine whether the pLVPK-like plasmid of CR-HvKP strains can be transferred to the E. coli or K. pneumoniae strain through conjugation. Strictly speaking, it is necessary to check whether pLVPK-like plasmids of HvKP can be transferred to CRKP ST11 strains. These experiments will provide data supporting Danxia et al.’s finding, the acquisition of the pLVPK-like plasmid by CRKP ST11 strains. Like Danxia et al.’s conjugation experiments, a study in 2014 showed the transmission and retainment of a resistance plasmid carrying blaKPC-2 from a classical ST258 K. pneumoniae to a recipient hypervirulent ST65 K. pneumoniae strain through conjugation [24]. These results raise the possibility for the horizontal transfer of resistance plasmids of CRKP into hypervirulent K. pneumoniae strains. When Danxia et al.’s study is included, the rate (56%, 23 of 41) of ST11 CR-HvKP isolates is far higher than that of ST23 and ST65 CR-HvKP (22%, 9 of 41) (Table 1). Although the number of currently identified CR-HvKP isolates is too small (41 isolates), these investigations may imply that the transmission of pLVPK-like plasmids from HvKP strains to CRKP strains seems to be a prevalent event. If the transfer rates of pLVPK-like and blaKPC-2-horboring plasmids between HvKP and CRKP are compared through conjugation experiments, it can provide additional information about plasmid-mediated convergence of carbapenem-resistance and hypervirulence.

Among 78 capsular serotypes of K. pneumoniae, K1 and K2 serotypes have known to be strongly associated with HvKP [6,10,25]. However, only 36% (15 of 41) of CR-HvKP isolates belonged to the K1/K2 capsule type (Table 1). Danxia et al. showed that ST11 CRKP strains with the K47 capsular serotype exhibit the hypervirulent phenotype only by acquiring the pLVPK-like plasmid [12]. Therefore, these results imply that more extensive studies are required to exactly establish the relationship between hypervirulence and the K1/K2 capsular type.

Scope for Further Studies

First, 25% of CR-HvKP strains belonged to ST65 or ST23. Because ST23 and ST65 is the dominant clone of HvKP in China [6], these results imply the transmission of the resistance plasmid from CRKP to HvKP. China is the region with the high prevalence of HvKP as well as CRKP strains [3,6,26].

Therefore, there is always the possibility for an alarming evolutionary event (the plasmid-mediated convergence of carbapenem-resistance and hypervirulence). Because one of two possible mechanisms of the plasmid-mediated convergence was proved, another mechanism (the horizontal transfer of resistance plasmids) of the convergence should be examined. If the horizontal transfer of resistance plasmids into HvKP strains is proved, the potential threat of CR-HvKP strains will increase. Because various features (size, conjugation efficiency, etc.) of the resistance plasmid are different to those of the virulence plasmid, such as the pLVPKlike plasmid, the study about the horizontal transfer of resistance plasmids into HvKP strains may also have a clinical importance.

Second, the horizontal transfer of resistance or virulence plasmids between CRKP and HvKP is not confirmed by conjugation experiment. Although the horizontal transfer of resistance plasmids harboring the bla_KPC-2 gene to E. coli [12] or ST65 HvKP [24] was confirmed through conjugation experiments, it did not examine whether the pLVPK-like plasmid of HvKP can be transferred to CRKP through conjugation. There is only one plasmid sequence (AY378100) of pLVPK or pLVPK-like plasmid deposited in GenBank. The bioinformatic analysis of this sequence shows that any tra gene (traABCDEFGHIKLNPQSTUVWX) is not present in the pLVPK plasmid. However, the tra operon can be located in various intracellular places, including another plasmid in the same host cell and the bacterial genome [27]. In addition, besides conjugation, there are other mechanisms of horizontal gene transfer, such as membrane vesicle and autolysis [28]. Based on these characteristics of the pLVPK or pLVPK-like plasmid, the horizontal transfer of these plasmids from HvKP to CRKP has to be confirmed by conjugation experiment.

Conflict of Interests

The authors declare that they have no competing interests.

Acknowledgments

This work was supported by research grants from the Bio & Medical Technology Development Program of the NRF funded by the MSIT (numbers NRF-2017M3A9E4078014 and NRF-2017M3A9E4078017); the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT (numbers NRF-2017R1A2B4002315 and NRF-2016R1C1B2010308); and the Research of Korea Centers for Disease Control and Prevention (number 2017NER5404- 00).

References

1. Lee CR, Cho IH, Jeong BC, Lee SH. Strategies to minimize antibiotic resistance. Int J Environ Res Public Health 2013; 10: 4274-4305.
2. Nathan C, Cars O. Antibiotic resistance-problems, progress, and prospects. N Engl J Med 2014; 371: 1761-1763.
3. Lee CR, Lee JH, Park KS, Kim YB, Jeong BC, Lee SH. Global dissemination of carbapenemase-producing Klebsiella pneumoniae: epidemiology, genetic context, treatment options, and detection methods. Front Microbiol 2016; 7: 895.
4. Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 2009; 9: 228-236.
5. Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 2011; 17: 1791-1798.
6. Lee CR, Lee JH, Park KS, Jeon JH, Kim YB, Cha CJ, Jeong BC, Lee SH. Antimicrobial resistance of hypervirulent Klebsiella pneumoniae: epidemiology, hypervirulence-associated determinants, and resistance mechanisms. Front Cell Infect Microbiol 2017; 7: 483.
7. Prokesch BC, TeKippe M, Kim J, Raj P, TeKippe EM, Greenberg DE. Primary osteomyelitis caused by hypervirulent Klebsiella pneumoniae. Lancet Infect Dis 2016; 16: 190-195.
8. Shon AS, Bajwa RP, Russo TA. Hypervirulent (hypermucoviscous) Klebsiella pneumoniae: a new and dangerous breed. Virulence 2013; 4: 107-118.
9. Struve C, Roe CC, Stegger M, Stahlhut SG, Hansen DS, Engelthaler DM, Andersen PS, Driebe EM, Keim P, Krogfelt KA. Mapping the evolution of hypervirulent Klebsiella pneumoniae. MBio 2015; 6: 00630.
10. Paczosa MK, Mecsas J. Klebsiella pneumoniae: going on the offense with a strong defense. Microbiol Mol Biol Rev 2016; 80: 629-661.
11. Li H, Zhang J, Liu Y, Zheng R, Chen H, Wang X, Wang Z, Cao B, Wang H. Molecular characteristics of carbapenemase-producing Enterobacteriaceae in China from 2008 to 2011: predominance of KPC-2 enzyme. Diagn Microbiol Infect Dis 2014; 78: 63-65.
12. Gu D, Dong N, Zheng Z, Lin D, Huang M, Wang L, Chan EW, Shu L, Yu J, Zhang R, Chen S. A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study. Lancet Infect Dis 2017; 18: 37-46.
13. Wei DD, Wan LG, Deng Q, Liu Y. Emergence of KPC-producing Klebsiella pneumoniae hypervirulent clone of capsular serotype K1 that belongs to sequence type 11 in Mainland China. Diagn Microbiol Infect Dis 2016; 85: 192-194.
14. Wu H, Li D, Zhou H, Sun Y, Guo L, Shen D. Bacteremia and other body site infection caused by hypervirulent and classic Klebsiella pneumoniae. Microb Pathog 2017; 104: 254-262.
15. Yao B, Xiao X, Wang F, Zhou L, Zhang X, Zhang J. Clinical and molecular characteristics of multi-clone carbapenem-resistant hypervirulent (hypermucoviscous) Klebsiella pneumoniae isolates in a tertiary hospital in Beijing, China. Int J Infect Dis 2015; 37: 107-112.
16. Zhan L, Wang S, Guo Y, Jin Y, Duan J, Hao Z, Lv J, Qi X, Hu L, Chen L, Kreiswirth BN, Zhang R, Pan J, Wang L, Yu F. Outbreak by hypermucoviscous Klebsiella pneumoniae ST11 isolates with carbapenem resistance in a tertiary hospital in China. Front Cell Infect Microbiol 2017; 7: 182.
17. Zhang R, Lin D, Chan EW, Gu D, Chen GX, Chen S. Emergence of carbapenem-resistant serotype K1 hypervirulent Klebsiella pneumoniae strains in China. Antimicrob Agents Chemother 2015; 60: 709-711.
18. Zhang Y, Zeng J, Liu W, Zhao F, Hu Z, Zhao C, Wang Q, Wang X, Chen H, Li H, Zhang F, Li S, Cao B, Wang H. Emergence of a hypervirulent carbapenem-resistant Klebsiella pneumoniae isolate from clinical infections in China. J Infect 2015; 71: 553-560.
19. Qi Y, Wei Z, Ji S, Du X, Shen P, Yu Y. ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China. J Antimicrob Chemother 2011; 66: 307-312.
20. Yang J, Ye L, Guo L, Zhao Q, Chen R, Luo Y, Chen Y, Tian S, Zhao J, Shen D, Han L. A nosocomial outbreak of KPC-2-producing Klebsiella pneumoniae in a Chinese hospital: dissemination of ST11 and emergence of ST37, ST392 and ST395. Clin Microbiol Infect 2013; 19: E509-515.
21. Guo Y, Wang S, Zhan L, Jin Y, Duan J, Hao Z, Lv J, Qi X, Chen L, Kreiswirth BN, Wang L, Yu F. Microbiological and clinical characteristics of hypermucoviscous Klebsiella pneumoniae isolates associated with invasive infections in China. Front Cell Infect Microbiol 2017; 7: 24.
22. Qu TT, Zhou JC, Jiang Y, Shi KR, Li B, Shen P, Wei ZQ, Yu YS. Clinical and microbiological characteristics of Klebsiella pneumoniae liver abscess in East China. BMC Infect Dis 2015; 15: 161.
23. Du P, Zhang Y, Chen C. Emergence of carbapenem-resistant hypervirulent Klebsiella pneumoniae. Lancet Infect Dis 2018; 18: 23-24.
24. Siu LK, Huang DB, Chiang T. Plasmid transferability of KPC into a virulent K2 serotype Klebsiella pneumoniae. BMC Infect Dis 2014; 14: 176.
25. Catalan-Najera JC, Garza-Ramos U, Barrios-Camacho H. Hypervirulence and hypermucoviscosity: Two different but complementary Klebsiella spp. phenotypes? Virulence 2017; 8: 1111-1123.
26. Chen L, Kreiswirth BN. Convergence of carbapenem-resistance and hypervirulence in Klebsiella pneumoniae. Lancet Infect Dis 2018; 18: 2-3.
27. R. Simon UP, A. Pühler. A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in Gram negative bacteria. Nature Biotechnology 1983; 1: 784-791.
28. Garcia-Aljaro C, Balleste E, Muniesa M. Beyond the canonical strategies of horizontal gene transfer in prokaryotes. Curr Opin Microbiol 2017; 38: 95-105.